Change in coronary heart disease hospitalization after chronic disease management: a programme policy in China.

Chronic disease management coronary heart disease direct medical cost hospitalization length of stay

Journal

Health policy and planning
ISSN: 1460-2237
Titre abrégé: Health Policy Plan
Pays: England
ID NLM: 8610614

Informations de publication

Date de publication:
13 Feb 2023
Historique:
received: 31 03 2022
revised: 04 11 2022
accepted: 23 11 2022
pubmed: 25 11 2022
medline: 15 2 2023
entrez: 24 11 2022
Statut: ppublish

Résumé

This study aims at examining changes in coronary heart disease (CHD) hospitalization associated with a novel county-scale chronic disease management (CDM) programme policy implemented in March 2019 in China during the 13th Five-Year period (2016-2020). The CDM programme was designed to improve the health of populations with chronic diseases by means of an integrated way involving both county-level public hospitals and primary care institutes. Data originated from the medical files of CHD inpatients discharged from a secondary hospital from January 2017 to December 2020. A total of 6111 CHD patient records were collected. Univariate and multivariate regression analyses were performed to assess changes in hospitalization direct medical costs and length of stay of CHD patients. The mean direct medical cost of CHD hospitalization was 8419.73 Yuan, and the mean length of stay was 7.57 days. Results suggested that the implementation of CDM reduced hospitalization direct medical cost and bed days by about 23% (1956.12 Yuan at means) and 11.5% (almost 1 day at means), respectively. In addition, a further decreasing trend in medical costs over time was associated with chronic disease management. It is implied that chronic disease management is an effective way of relieving the medical and financial burden of hospitalization.

Identifiants

pubmed: 36420873
pii: 6845428
doi: 10.1093/heapol/czac101
pmc: PMC9923378
doi:

Types de publication

Journal Article

Langues

eng

Pagination

161-169

Subventions

Organisme : National Natural Science Foundation of China
ID : 72042002
Organisme : National Natural Science Foundation of China
ID : 72061160491
Organisme : Cultural Expert and Four First-Class Talent Project "Research on Healthcare Reform Evaluation"

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine.

Références

Cardiovasc Drugs Ther. 2007 Oct;21(5):389-98
pubmed: 17805954
J Am Coll Cardiol. 2004 Aug 18;44(4):810-9
pubmed: 15312864
Heart. 2006 Oct;92(10):1384-9
pubmed: 16702172
Arq Bras Cardiol. 2000 Jun;74(6):483-92
pubmed: 10975138
Endocrinol Metab (Seoul). 2015 Jun;30(2):159-66
pubmed: 26194075
Medicine (Baltimore). 2015 May;94(20):e837
pubmed: 25997060
Eur Heart J Qual Care Clin Outcomes. 2022 Jan 5;8(1):50-60
pubmed: 33017008
Prev Chronic Dis. 2013;10:120112
pubmed: 23327828
Am J Med. 2011 Sep;124(9):827-33.e5
pubmed: 21722862
Int J Cardiol. 2016 Oct 1;220:745-9
pubmed: 27393860
Risk Manag Healthc Policy. 2020 Jul 31;13:969-978
pubmed: 32801971
J Hypertens. 1998 Aug;16(8):1099-100
pubmed: 9794710
Medicine (Baltimore). 2017 Dec;96(51):e9341
pubmed: 29390516
Lancet. 2007 Dec 8;370(9603):1929-38
pubmed: 18063029
Trop Med Int Health. 2021 Jul;26(7):829-837
pubmed: 33780099
Health Policy. 2010 May;95(2-3):271-6
pubmed: 20061044
Inquiry. 2019 Jan-Dec;56:46958019886958
pubmed: 31701787
BMC Health Serv Res. 2015 Apr 22;15:174
pubmed: 25895499
Am J Prev Med. 2017 Dec;53(6S2):S182-S189
pubmed: 29153119
J Prev Med Public Health. 2012 Sep;45(5):291-300
pubmed: 23091654
Arch Intern Med. 2007 Mar 26;167(6):551-61
pubmed: 17389286
J Chin Med Assoc. 2015 Nov;78(11):678-85
pubmed: 26341451
Chronic Dis Transl Med. 2017 Aug 10;3(3):135-137
pubmed: 29063067
Ann Intern Med. 2005 Nov 1;143(9):659-72
pubmed: 16263889
Eff Clin Pract. 1998 Aug-Sep;1(1):2-4
pubmed: 10345255
Health Qual Life Outcomes. 2016 Nov 15;14(1):159
pubmed: 27846850
Front Public Health. 2020 Jan 21;7:411
pubmed: 32039127
Clin Epidemiol. 2020 Feb 24;12:215-222
pubmed: 32158274
Pediatrics. 2012 Mar;129(3):465-72
pubmed: 22351890
Afr Health Sci. 2020 Dec;20(4):1716-1724
pubmed: 34394231
Intern Med J. 2008 Jun;38(6):427-37
pubmed: 18298554
Public Health. 2015 Jan;129(1):68-73
pubmed: 25542739
Res Social Adm Pharm. 2020 Sep;16(9):1155-1165
pubmed: 31959565
BMC Fam Pract. 2018 May 30;19(1):76
pubmed: 29843619
Heart. 1997 Dec;78(6):544-9
pubmed: 9470868
Arch Intern Med. 2003 Dec 8-22;163(22):2775-83
pubmed: 14662633
BMC Cancer. 2018 Jun 25;18(1):683
pubmed: 29940893
Hypertension. 2015 Sep;66(3):502-8
pubmed: 26169049

Auteurs

Jingmin Zhu (J)

Department of Epidemiology and Public Health, University College London, 1-19 Torrington Place, London WC1E 7HB, United Kingdom.

Wei Wang (W)

Department of Social and Preventive Medicine, University of Malaya, Level 5, Block I, Kuala Lumpur 50603, Malaysia.

Jun Wang (J)

Center for Health Policy Research and Evaluation, School of Public Administration and Policy, Renmin University of China, No. 59 Zhongguancun Street, Haidian District, Beijing 100872, China.

Liang Zhu (L)

Henan Province Yongcheng Central Hospital, Zhongyuan Road, Yongcheng, Shangqiu 476610, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH